ACAD vs NCI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
ACAD
NCI
Investment Advisor Scores
NCI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ACAD | NCI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 73.5294 | 0 | Tie |
| PEG Ratio | 50.8642 | 1.13 | NCI |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 16.4% | -50.8% | ACAD |
| Earnings Growth | 13.3% | 34.0% | NCI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 47.6/100 | 41.0/100 | ACAD |
| Profit Margin | 33.4% | 0.2% | ACAD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ACAD
MarkupPrice above SMA50, rising 50-day trend (11.6% over 20 days), RSI 63
NCI
MarkupPrice above SMA50, rising 50-day trend (15.4% over 20 days), RSI 69
Fundamentals Snapshot
| Metric | ACAD | NCI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 33.2 | 0.0 |
| Trailing P/E | 13.6 | 155.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | -0.5% |
| Gross Margin | 0.6% | 0.4% |
| Operating Margin | 0.1% | 0.0% |
| EPS | 2.14 | 0.08 |
| Dividend Yield | — | — |